Perritt Capital Management Inc, a Illinois-based fund reported 50,000 shares.#img1#. They set a "buy" rating and a $32.00 price target for the company. Zacks Investment Research cut Cutera from a "hold" rating to a "sell" rating in a research note on Thursday, May 4th. The stock was sold at an average price of $22.31, for a total transaction of $874,641.24. Finally, Maxim Group reiterated a buy rating and issued a $33.00 price objective (up previously from $27.00) on shares of Cutera in a research note on Thursday, July 13th. It increased, as 3 investors sold Cutera, Inc. shares while 17 reduced holdings. The company had a trading volume of 75,634 shares. Cutera, Inc. has a 52-week low of 10.54 and a 52-week high of 34.00. The stock's 50-day moving average price is $26.06 and its 200-day moving average price is $21.93. The firm has a market cap of $369.32 million, a PE ratio of 102.11 and a beta of 0.60. As of the end of the quarter Gamco Investors, Inc. Institutional investors and hedge funds own 82.87% of the company's stock. The business had revenue of $36.40 million during the quarter, compared to the consensus estimate of $32.08 million. Cutera had a return on equity of 9.21% and a net margin of 2.89%. The same analysts have a future one-year price target of $32.33 on the shares. During the same quarter a year ago, the business posted $0.07 earnings per share. The medical device company reported $0.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.10, Briefing.com reports. TheStreet downgraded shares of Cutera from a "b-" rating to a "c" rating in a report on Monday, May 1st. This buyback authorization allows the medical device company to reacquire up to 6.8% of its stock through open market purchases.
TRADEMARK VIOLATION NOTICE: "Cutera, Inc". (NASDAQ:CUTR) on Tuesday, June 27 with "Buy" rating. If you are reading this article on another site, it was stolen and reposted in violation of US and global trademark and copyright legislation. The original version of this news story can be viewed at https://www.themarketsdaily.com/2017/08/08/cutera-inc-nasdaqcutr-price-target-increased-to-39-00-by-analysts-at-roth-capital.html. Also, EVP Larry Laber sold 1,000 shares of Cutera stock in a transaction dated Wednesday, June 28th. Also, CFO Ronald J. Santilli sold 3,857 shares of the business's stock in a transaction that occurred on Thursday, June 1st. Following the sale, the executive vice president now directly owns 73,140 shares of the company's stock, valued at approximately $1,892,863.20. 186,505 shares of the stock were exchanged. The shares sold for $25.88. The disclosure for this sale can be found here. The value of the investment in (CUTR) increased from $1,180,000 to $1,513,000 increasing 28.2% quarter over quarter. Insiders own 3.30% of the company's stock. Federated Investors Inc. PA increased its position in shares of Cutera by 2.5% in the second quarter. American International Group Inc. now owns 7,221 shares of the medical device company's stock valued at $149,000 after buying an additional 475 shares during the last quarter. Metropolitan Life Insurance Co.
Cutera announced that its Board of Directors has approved a stock repurchase plan on Monday, August 7th that allows the company to buyback $25.00 million in shares.
Bill Murray Relived Groundhog Day Again at the Broadway Musical - and Cried
We just have to try again. "As actors, I can't respect enough how disciplined you are and how serving you are of the process", Mr. He addressed the cast backstage, telling them, "There's nothing worse than seeing someone that's out for themselves".
Lyon Street Capital Llc holds 5.37% of its portfolio in Cutera, Inc. for 605,629 shares. Russell Investments Group Ltd. purchased a new stake in shares of Cutera during the fourth quarter worth about $321,000.
Larry Laber, EVP, North America Sales disclosed the sale of 2,563 shares. Finally, Driehaus Capital Management LLC bought a new stake in shares of Cutera during the first quarter valued at about $363,000.
Cutera, Inc., launched on August 10, 1998, is a medical device company. The company engages in sale of aesthetic medical equipment and services, and distribution of cosmeceutical and dermal filler products to qualified medical practitioners.
- SCS Group PLC 45.6% Potential Upside Indicated by finnCap
- North Korea Crosses Red Line, Can Fit Miniaturized Nuke in Missile Warhead
- India Blocks Internet Archive
- Vanguard Group Inc. Boosts Position in PBF Energy Inc. (NYSE:PBF)
- Team Sky Rider Breaks Leg On Brother's Stag Party
- Vidéo : Sébastien Loeb dans la Citroën C3
- DXC Technology reveals first post-merger financials
- The Anthem, Inc. (NYSE:ANTM) Shares Sold by Spinnaker Trust
- GCAA denies reports of eased airspace restrictions for Qatar planes
- Price Target Analysis of Cisco Systems, Inc. (CSCO)